CY1106086T1 - Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα - Google Patents

Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Info

Publication number
CY1106086T1
CY1106086T1 CY20061100500T CY061100500T CY1106086T1 CY 1106086 T1 CY1106086 T1 CY 1106086T1 CY 20061100500 T CY20061100500 T CY 20061100500T CY 061100500 T CY061100500 T CY 061100500T CY 1106086 T1 CY1106086 T1 CY 1106086T1
Authority
CY
Cyprus
Prior art keywords
methylon
androgens
beta
substituted
preparation
Prior art date
Application number
CY20061100500T
Other languages
Greek (el)
English (en)
Inventor
Dirk Leysen
Jaap Van Der Louw
Roberta Buma Bursi
Marcel Evert De Gooyer
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1106086T1 publication Critical patent/CY1106086T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
CY20061100500T 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα CY1106086T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens
EP00993259A EP1237904B1 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (1)

Publication Number Publication Date
CY1106086T1 true CY1106086T1 (el) 2011-06-08

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100500T CY1106086T1 (el) 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Country Status (27)

Country Link
US (1) US6706700B2 (enExample)
EP (1) EP1237904B1 (enExample)
JP (1) JP2003515543A (enExample)
CN (1) CN1166680C (enExample)
AR (1) AR026655A1 (enExample)
AT (1) ATE317396T1 (enExample)
AU (1) AU778017B2 (enExample)
CA (1) CA2390226A1 (enExample)
CO (1) CO5251441A1 (enExample)
CY (1) CY1106086T1 (enExample)
CZ (1) CZ301376B6 (enExample)
DE (1) DE60025958T2 (enExample)
DK (1) DK1237904T3 (enExample)
ES (1) ES2258037T3 (enExample)
HK (1) HK1047596B (enExample)
HU (1) HUP0203611A3 (enExample)
IL (1) IL149424A (enExample)
MX (1) MXPA02004939A (enExample)
NO (1) NO322422B1 (enExample)
NZ (1) NZ518753A (enExample)
PE (1) PE20011033A1 (enExample)
PL (1) PL202999B1 (enExample)
RU (1) RU2242479C2 (enExample)
SK (1) SK287095B6 (enExample)
TW (1) TWI275593B (enExample)
WO (1) WO2001040255A2 (enExample)
ZA (1) ZA200203536B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
RS51490B (sr) * 2002-01-21 2011-04-30 N.V. Organon POSTUPAK ZA IZRADU 7α-METILSTEROIDA
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2764008T3 (pl) * 2011-10-07 2017-04-28 Estetra S.P.R.L. Sposób wytwarzania estetrolu
JP6863547B2 (ja) 2015-06-18 2021-04-21 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
HUP0203611A3 (en) 2004-07-28
JP2003515543A (ja) 2003-05-07
ZA200203536B (en) 2003-08-04
SK287095B6 (sk) 2009-12-07
CZ20021894A3 (cs) 2002-08-14
EP1237904A2 (en) 2002-09-11
AU778017B2 (en) 2004-11-11
WO2001040255A2 (en) 2001-06-07
ATE317396T1 (de) 2006-02-15
CZ301376B6 (cs) 2010-02-03
NO20022564D0 (no) 2002-05-30
NO322422B1 (no) 2006-10-02
CN1402735A (zh) 2003-03-12
ES2258037T3 (es) 2006-08-16
TWI275593B (en) 2007-03-11
CA2390226A1 (en) 2001-06-07
PE20011033A1 (es) 2001-10-11
US6706700B2 (en) 2004-03-16
DK1237904T3 (da) 2006-06-06
DE60025958T2 (de) 2006-07-27
CN1166680C (zh) 2004-09-15
AU2838301A (en) 2001-06-12
NZ518753A (en) 2004-05-28
SK7582002A3 (en) 2002-09-10
DE60025958D1 (de) 2006-04-20
IL149424A (en) 2007-05-15
EP1237904B1 (en) 2006-02-08
IL149424A0 (en) 2002-11-10
PL355689A1 (en) 2004-05-17
HK1047596B (en) 2006-04-21
PL202999B1 (pl) 2009-08-31
CO5251441A1 (es) 2003-02-28
US20030100543A1 (en) 2003-05-29
NO20022564L (no) 2002-05-30
RU2242479C2 (ru) 2004-12-20
MXPA02004939A (es) 2003-05-23
HUP0203611A2 (hu) 2003-03-28
AR026655A1 (es) 2003-02-19
HK1047596A1 (en) 2003-02-28
WO2001040255A3 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
CY1106086T1 (el) Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
CY1109404T1 (el) Μεθοδος δια την παρασκευη προϊοντων στεροειδους ορμονης. η οποια περιλαμβανει παραγοντα σταθεροποιησεως εις μη-κρυσταλλικην μορφη
ZA200107631B (en) Indoline derivatives as progesterone antagonists.
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
CY1106463T1 (el) Τοπικη ορμονικη συνθεση με συστημικο αποτελεσμα
TR199800648A1 (xx) �ki veya daha fazla etken madde i�in ila� verme sistemi.
TR200101822T2 (tr) Kontrollü salınan galantamin bileşimi
CY1105065T1 (el) Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση
MY111841A (en) Injectable liposomal pharmaceutical preparations
NO965516L (no) Sterolderivater anvendt til regulering av meiose
DK0902789T3 (da) Androstenderivater
FI20011703A7 (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
CY1115064T1 (el) Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
IL139861A (en) 17beta-AMINO-AND HYDROXYLAMINO -11 beta - ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ATE225800T1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
BG104424A (en) Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
EE05186B1 (et) 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid
MX9300677A (es) Procedimiento mejorado para la preparacion de dienos esteroidales substituidos.